Characteristics and initial laboratory values of 213 patients with CMML
Variable . | Median . | Range . |
---|---|---|
Age, y | 65 | 20-88 |
Male, no. (%) | 150 (70.4) | — |
Female, no. (%) | 63 (29.6) | — |
Hemoglobin, g/L (g/dL) | 102 (10.2) | 52-156 (5.2-15.6) |
Platelet count, × 109/L | 87 | 4-706 |
White blood cell count, × 109/L | 20.4 | 2.1-352 |
Neutrophils, % | 46 | 3-81 |
Neutrophils, × 109/L | 9.8 | 0.3-186.5 |
Monocytes, % | 22 | 8-92 |
Monocytes, × 109/L | 4.2 | 1.0-162 |
Lymphocytes, % | 15 | 1-57 |
Lymphocytes, × 109/L | 3.1 | 0.3-22.9 |
Eosinophils, % | 0 | 0-30 |
Basophils, % | 0 | 0-9 |
Blasts plus promyelocytes, % | 0 | 0-22 |
Myelocytes plus metamyelocytes, % | 3 | 0-32 |
Peripheral blood IMCs, % | 3 | 0-38 |
Bone marrow blasts, % | 4 | 0-19 |
Bone marrow monocytes, % | 12.2 | 0.3-78 |
Bone marrow lymphocytes, % | 5.8 | 0-47 |
Bone marrow erythroid cells, % | 13.4 | 0.4-65.4 |
Myeloid–erythroid cell ratio | 4.3 | 0.2-192 |
LDH, U/L | 783 | 270-5310 |
β2-microglobulin, mg/L* | 3.8 | 1-15.1 |
Variable . | Median . | Range . |
---|---|---|
Age, y | 65 | 20-88 |
Male, no. (%) | 150 (70.4) | — |
Female, no. (%) | 63 (29.6) | — |
Hemoglobin, g/L (g/dL) | 102 (10.2) | 52-156 (5.2-15.6) |
Platelet count, × 109/L | 87 | 4-706 |
White blood cell count, × 109/L | 20.4 | 2.1-352 |
Neutrophils, % | 46 | 3-81 |
Neutrophils, × 109/L | 9.8 | 0.3-186.5 |
Monocytes, % | 22 | 8-92 |
Monocytes, × 109/L | 4.2 | 1.0-162 |
Lymphocytes, % | 15 | 1-57 |
Lymphocytes, × 109/L | 3.1 | 0.3-22.9 |
Eosinophils, % | 0 | 0-30 |
Basophils, % | 0 | 0-9 |
Blasts plus promyelocytes, % | 0 | 0-22 |
Myelocytes plus metamyelocytes, % | 3 | 0-32 |
Peripheral blood IMCs, % | 3 | 0-38 |
Bone marrow blasts, % | 4 | 0-19 |
Bone marrow monocytes, % | 12.2 | 0.3-78 |
Bone marrow lymphocytes, % | 5.8 | 0-47 |
Bone marrow erythroid cells, % | 13.4 | 0.4-65.4 |
Myeloid–erythroid cell ratio | 4.3 | 0.2-192 |
LDH, U/L | 783 | 270-5310 |
β2-microglobulin, mg/L* | 3.8 | 1-15.1 |
Data available for 64 patients.